Medique Aspirin

Medique Aspirin

Medique Aspirin Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


1.1 Rheumatoid Arthritis including Polyarticular Juvenile Idiopathic Arthritis

Rasuvo is indicated in the management of selected adults with severe, active rheumatoid arthritis (RA) (ACR criteria), or children with active polyarticular juvenile idiopathic arthritis (pJIA), who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs).

1.2 Psoriasis

Rasuvo is indicated in adults for the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation. It is important to ensure that a psoriasis "flare" is not due to an undiagnosed concomitant disease affecting immune responses.

1.3 Limitation of Use

Rasuvo is not indicated for the treatment of neoplastic diseases.


There is currently no drug history available for this drug.

Other Information

Rasuvo contains methotrexate, a folate analog metabolic inhibitor.

Chemically, methotrexate is [N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-Lglutamic acid. The structural formula is:

Chemical Structure

C20H22N8O5  M.W.= 454.45

Rasuvo contains methotrexate in a sterile, preservative-free, non-pyrogenic solution for a single subcutaneous injection. Rasuvo is an isotonic, clear, yellow to brown solution.

Rasuvo contains the following inactive ingredients: sodium chloride 0.4% w/v; water for injections, sodium hydroxide and, if necessary, hydrochloric acid are added to adjust the pH to approximately 8.5.

Medique Aspirin Manufacturers

  • Unifirst First Aid Corporation
    Medique Aspirin (Aspirin) Tablet, Film Coated Medi-first Aspirin (Aspirin) Tablet, Film Coated Medi First Plus Aspirin (Aspirin) Tablet, Film Coated [Unifirst First Aid Corporation]

Login To Your Free Account